deliv roughli in-lin result on-going strong script growth
strateg partnership continu somewhat off-set reimburs
pressure/tough retail environ addit rite-aid acquisit
nr continu progress cash flow remain solid on-going store
rejuven carri promis see continu reason optim
expect challeng retail environ persist would look on-going
reimburs pressur weigh continu view risk/reward
balanc maintain hold pt ep
rite-aid make progress decemb end rite-aid acquisit
track store acquir manag plan continu
acquir outstand store phase goal complet
spring year full integr cost
expect store closur still stand store like
begin immedi follow acquisit complet expens
anticip synergi expect gener annual cost
save within four year transact close continu view
deal favor tie complementari geograph footprint
net revenu came ahead estim tie
better expect result across segment us retail pharmaci
standout perform vs strh continu gain
script volum drove beat adj script count slightli
ahead estim ss volum contribut
strateg partnership retail sale same-stor
fuel declin consumables/person care mitig continu
strong growth key beauti well categori see page
strong top-lin result partial off-set uptick sg
revenu vs strhe tax rate lead adj ep
two cent estim
detail cffo
estim driven pronounc work capit drag vs
estim inventori build on-going invest beauti
addit compani complet share repurchas program
expans rais lower end full-year ep guidanc
five cent
tr target
estim tweak modestli bump estim reflect revis guidanc
adj ep estim rais
page
beauti build updat
continu invest high margin beauti segment roll-out enhanc beauti
offer addit store bring total launch new skincar brand
skin invest continu show encourag result beauti sale enhanc
beauti offer store outpac store total beauti categori sale compris
retail sale addit effort improv custom experi continu make
improv it/digit capabl includ mobil app million
download lastli shift strateg presenc china acquisit gouda
drugstor lead retail chain sale part wholesal partnership invest
pharmaceut wholesal divis post revenu come ahead
estim ss growth came cc bit shi growth target challeng
market condit off-set strong result emerg market
retail pharmaci revenu came ahead estim
beat primarili due favor currenc translat sale cc basi overal
ss sale fell cc ss pharmaci cc retail sale cc boot
uk ss pharmaci increas cc temporari gener price increas ss retail sale fell
page
revenu
revenu
revenu
net incom
non-gaap add back tax
adjust net incom
page
inc global leader pharmaceut servic industri
store prior pend deal sizabl wholesale/distribut network countri
compani largest retail pharmaci unit state retail pharmaci usa divis
gener total compani revenu remain sale come
retail intern pharmaci revenu wholesal revenu
bullish underli trend pharmaceut servic expect sever tailwind
age popul util growth increas gener penetr growth specialti drive on-going
growth sector forese futur believ recent format sever strateg
partnership optum prime tricar demonstr valu compani scale/cap
provid near term volum tailwind reason optim challeng exist
 retail pharmaci busi continu see margin pressur tie sever factor
rate price pressur payer contract increasingli difficult overal retail environ
valuat risk
hold rate price target base stock trade adjust
cash ep slight discount current multipl upbeat underli
trend pharmaceut servic view compani scale key differenti upbeat
pend deal like compani free cash flow gener view risk/
reward balanc given us pharmaci margin pressur like linger difficult
retail environ upsid risk price target includ better synergi captur stronger core trend
dissip pbm margin pressur aggress capit deploy downsid risk includ
issu integr increas price pressur addit retail competit
compani mention note
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
